SS
ENVB icon

SBI Securities’s Enveric Biosciences ENVB Stock Holding History

SBI Securities’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Buy
2,676
+2,593
+3,124% +$6.23K ﹤0.01% 2318
2026
Q1 		$161 Buy
83
+34
+69% +$93 ﹤0.01% 3289
2025
Q4 		$178 Sell
49
-1
-2% -$7 ﹤0.01% 3246
2025
Q3 		$384 Hold
50
– – ﹤0.01% 3076
2025
Q2 		$726 Sell
50
-10
-17% -$152 ﹤0.01% 2816
2025
Q1 		$1.01K Buy
+60
New +$2.08K ﹤0.01% 2581
2024
Q4 		– Hold
0
– – – 3962

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

SBI Securities's ENVB Position: Q2 2026 in Review

SBI Securities increased its Enveric Biosciences (ENVB) stake by 3,124% in Q2 2026, buying an estimated $6.23K and bringing the position to 2,676 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

SBI Securities first reported a position in ENVB in Q1 2025 and has held it in 6 quarters since. 15 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • SBI Securities held 2,676 shares of Enveric Biosciences worth $3.69K as of Q2 2026.
  • SBI Securities bought 2,593 Enveric Biosciences shares in Q2 2026, an estimated $6.23K.
  • Enveric Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2318 holding.
  • SBI Securities first reported a position in Enveric Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 15 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.